#46
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Ðåñóðñ äëÿ ïðîôåññèîíàëîâ è íàñåëåíèÿ. |
#47
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Unnecessary Testing in Obstetrics, Gynecology, and General Medicine: Causes and Consequences of the Unwarranted Use of Costly and Unscientific (Yet Profitable) Screening Modalities Martin Donohoe, MD, FACP Medscape Ob/Gyn & Women's Health. 2007; ©2007 Medscape Posted 04/30/2007 Overview Unnecessary testing is becoming increasing common in medical practice and consumer demand for certain types of tests have escalated. Such testing is expensive, diverts patient and provider time and attention from addressing evidence-based screening, can provide unwarranted reassurance or cause unnecessary anxiety, and can lead to further interventions that may carry risks of physical harm and even death. This column will provide an overview of unnecessary testing, using examples from obstetrics, gynecology, and general medicine. There is a large body of evidence-based literature describing the extent, reasons for, and consequences of inappropriate use of laboratory tests, especially in the hospital setting. However, this column will focus primarily on more expensive screening tests, such as full-body scans, which are often marketed directly to unwitting consumers. |
#48
|
|||
|
|||
Best Pract Res Clin Obstet Gynaecol. 2007 May 10; [Epub ahead of print] Related Articles, LinkOut
Current treatment options for abnormal uterine bleeding: an evidence-based approach. Istre O, Qvigstad E. Department of Obstetrics and Gynaecology, Ulleval University Hospital, Oslo, Norway. Heavy menstrual bleeding is the predominant complaint in women with abnormal uterine bleeding\. Treatment options are drug therapy, and first- and second-generation endometrial resection\. Many women will subsequently have a hysterectomy\. Uterine fibroids are the most common solid pelvic tumours in women, and although many fibroids seem to cause no symptoms, they can have serious adverse effects and impact on quality of life\. As women postpone having children, gynaecologists will have to manage fibroids and polyps in a conservative manner\. The past decade has witnessed the development of highly sophisticated diagnostic and therapeutic technology for women suffering from menorrhagia, fibroids and polyps, including minimally invasive uterine therapy\. The tools currently at our disposal permit greater management flexibility, which must be tailored to the individual clinical situation\. This chapter reviews the evidence-based approach and minimally invasive therapy. PMID: 17499553 [PubMed - as supplied by publisher] |
#49
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Summaries and commentary of medical journal articles covering women's health issues including menopause, pregnancy, and infertility. |
#50
|
||||
|
||||
Atlas of Vulvar Disease
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Àòëàñ çàáîëåâàíèé âóëüâû Äîâîëüíî öåííûé àòëàñ,â òîì ñìûñëå,÷òî ôîòî íåêîòîðûõ çàáîëåâàíèé â ñåòè íå íàéäåøü.Åñëè åñòü âîçìîæíîñòü çàïëàòèòü $ - ìîæíî ïîëó÷èòü è âèäåîðîëèêè. |
#51
|
||||
|
||||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì] |
#52
|
|||
|
|||
|
|
#53
|
|||
|
|||
Êóðñ óñîâåðøåíñòâîâàíèÿ ïðåïîäàâàòåëåé. Êîìïëåêñíàÿ ïðîãðàììà îáó÷åíèÿ ðåïðîäóêòèâíîìó çäîðîâüþ è ïëàíèðîâàíèþ ñåìüè - 2007 ã.
(Advanced Training of Trainers. Comprehensive Reproductive Health and Family Planning Training Curriculum) (íà àíãë.ÿç) Àâòîð: Pathfinder International Îïèñàíèå Ýòîò ìîäóëü, âêëþ÷àþùèé ðóêîâîäñòâà êàê äëÿ ïðåïîäàâàòåëÿ, òàê è äëÿ ó÷àñòíèêà îáó÷åíèÿ, ðàçðàáîòàí ñ öåëüþ ïîäãîòîâêè ïðåïîäàâàòåëåé, óæå îáëàäàþùèõ íàâûêàìè ïðåïîäàâàíèÿ òåìû ðåïðîäóêòèâíîãî çäîðîâüÿ, äëÿ äîñòèæåíèÿ áîëåå âûñîêîãî óðîâíÿ ïðîâåäåíèÿ ïîäãîòîâêè. Ðóêîâîäñòâî ãîòîâèò ïðåïîäàâàòåëåé äëÿ ïðîâåäåíèÿ îöåíêè ïîòðåáíîñòè â ïîäãîòîâêå, ñîñòàâëåíèÿ äåòàëüíûõ ïëàíîâ òðåíèíãà, ðàçðàáîòêè è àïðîáàöèè ïðîãðàììû îáó÷åíèÿ òðåíèíãà, ïðîâåäåíèÿ ïîäãîòîâêè ñ ïðèìåíåíèåì áîëåå ñîâåðøåííûõ ïåäàãîãè÷åñêèõ ïðèåìîâ è ïîñëåäóþùåé ïðîâåðêè ðåçóëüòàòîâ è îöåíêè òðåíèíãà. Êàê ïîëó÷èòü È Ðóêîâîäñòâî äëÿ ïðåïîäàâàòåëÿ, è Ðóêîâîäñòâî äëÿ ó÷àñòíèêà ìîæíî âûãðóçèòü â âèäå ôàéëîâ PDF. Çàêàç ïå÷àòíûõ ýêçåìïëÿðîâ ïî àäðåñó [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#54
|
|||
|
|||
Ïëàíèðîâàíèå ñåìüè: Ãëîáàëüíûé ñïðàâî÷íèê
(Family Planning: A Global Handbook for Providers) (íà àíãë.ÿç) Àâòîð: Øêîëà îáùåñòâåííîãî çäðàâîîõðàíåíèÿ èìåíè Áëþìáåðãà ïðè Óíèâåðñèòåòå Johns Hopkins Îïèñàíèå Ýòîò íîâûé ñïðàâî÷íèê ïðåäëàãàåò ìåäèöèíñêèì ðàáîòíèêàì â ðàçâèâàþùèõñÿ ñòðàíàõ ñàìûå ïîñëåäíèå ðåêîìåíäàöèè ïî èñïîëüçîâàíèÿ ìåòîäîâ êîíòðàöåïöèè. Êíèãà ïîäãîòîâëåíà áëàãîäàðÿ óíèêàëüíîìó ñîòðóäíè÷åñòâó ìåæäó Øêîëîé îáùåñòâåííîãî çäðàâîîõðàíåíèÿ èìåíè Áëþìáåðãà ïðè Óíèâåðñèòåòå Johns Hopkins, Àãåíòñòâîì ïî ìåæäóíàðîäíîìó ðàçâèòèþ Ñîåäèíåííûõ Øòàòîâ è áîëåå ÷åì 30 îðãàíèçàöèÿìè âî âñåì ìèðå. Êàê ïîëó÷èòü Èìååòñÿ â ôîðìàòå PDF [372 ñòð.]. Ïå÷àòíûå ýêçåìïëÿðû êíèãè Ïëàíèðîâàíèå ñåìüè: Ãëîáàëüíûé ñïðàâî÷íèê äëÿ ïðîâàéäåðîâ è ñîïðîâîæäàþùèé åå íàñòåííûé ïëàêàò "Çíàåòå ëè âû î ñâîèõ âîçìîæíîñòÿõ ïëàíèðîâàíèÿ ñåìüè?" ìîæíî çàêàçàòü â îòäåëå çàêàçîâ Ïðîåêòà INFO [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]). Îðãàíèçàöèÿì èç ðàçâèâàþùèõñÿ ñòðàí ñïðàâî÷íèê ïðåäîñòàâëÿåòñÿ áåñïëàòíî. Äëÿ îðãàíèçàöèé èç ðàçâèòûõ ñòðàí öåíà çà ýêçåìïëÿð ñîñòàâèò 24,95 äîëëàðà ÑØÀ. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#55
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Family Care International (FCI) is a non-profit organization dedicated to making pregnancy and childbirth safer around the world - Ensure access to quality maternal and newborn health care; - Help women and girls to prevent and manage unintended pregnancy; - Promote the sexual and reproductive health and rights of young people and other underserved groups; - Reduce the spread of HIV, especially among women and young people. |
#57
|
|||
|
|||
New Checklist for Screening Clients Who Want to Initiate Contraceptive Implants
October 2008 Family Health International (FHI) is pleased to announce the release of a new family planning checklist for screening clients who want to initiate the use of contraceptive implants. Contraceptive implants are matchstick-sized rods that contain progestin. Implanted beneath the skin of a woman’s upper arm, the progestin is slowly released over 3 to 5 years. Contraceptive implants, such as Norplant, Jadelle, Sinoplant, and Implanon, are safe and effective for use by most women. For some women, implants are generally not recommended because of the presence of certain medical conditions, such as some liver tumors or breast cancer. This new checklist is designed to help health care providers screen clients for certain medical conditions to determine if they are appropriate candidates. The implants checklist is based on recommendations included in the World Health Organization’s Medical Eligibility Criteria for Contraceptive Use (WHO MEC 2004; updated 2008). The checklist can be used by appropriately trained health care providers including nurses, nurse-midwives, nurse-practitioners, midwives, and physicians. This checklist is part of a series of screening checklists for family planning services, all of which have been recently updated to reflect changes in WHO’s guidance that resulted from an April 2008 WHO Working Group Meeting. The other checklists include the Checklist for Screening Clients Who Want to Initiate Combined Oral Contraceptives, the Checklist for Screening Clients Who Want to Initiate DMPA (or NET-EN), the Checklist for Screening Clients Who Want to Initiate Use of the Copper IUD, and the checklist entitled How to be Reasonably Sure a Client is Not Pregnant. These are available in English, French, and Spanish. The implants checklist will soon be available in French. They can all be downloaded at the following link: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]. Hard copies of all five checklists are also available at no cost to organizations and libraries working in developing countries. To request hard copies, please email your request to [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]. David Hock Family Health International [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#58
|
|||
|
|||
Ïîêàçàíèÿ è îãðàíè÷åíèå ê ïðèìåíåíèþ ÊÎÊ, ÂÌÑ è êîíòðàöåïòèâîâ, ñîäåðæàùèõ ÷èñòûå ïðîãåñòèíû , íå èçìåíèëèñü. Êîíòðàöåïòèâû â ôîðìå ïîäêîæíûõ èìïëàíòîâ â íàøåé ñòðàíå íå çàðåãèñòðèðîâàíû.
 êîíöå 80-õ íà÷àëå 90-õ ãîäîâ â Ìîñêâå ïðîõîäèë êëèíè÷åñêèå èñïûòàíèÿ Íîðïëàíò (ïîäêîæíûå êàïñóëû ñ ëåâîíîðãåñòðåëîì), îáåñïå÷àâàþùèé êîíòðàöåïòèâíûé ýôôåêò íà 3-5 ëåò. Íî ðåãèñòðàöèè â Ôàðìêîìèòåòå íå áûëî - ïðè÷èíà îòêàçà îñòàëàñü òàéíîé. |
#59
|
|||
|
|||
POPLINER(POPulation information onLINE),
the world's largest database on reproductive health, containing citations with abstracts to scientific articles, reports, books, and unpublished reports in the field of population, family planning, and related health issues. POPLINE is maintained by the INFO Project at the Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs and is funded by the United States Agency for International Development (USAID). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] SUBJECTS Covered Internationally Include: Family Planning Methods Medical and behavioral methods used in the regulation of fertility. Family Planning Programs Organization, management, delivery, and evaluation of family planning services to men and women of reproductive age, including clinical services, community-based distribution, social marketing, contraceptive security, Maximizing Access and Quality (MAQ) of family planning and other non-clinical or commercial services. Fertility The demographic measurement of births in a population; includes the effect of socioeconomic variables and of programs and policies on reproductive performance status and change. Population Law and Policy Positions, legislation or actions taken by governments and other public bodies toward reproduction, contraception, migration, and family size. SUBJECTS Covered in Reference to Developing Countries Include: Adolescent Reproductive Health Sexual and reproductive health of adolescent men and women. Demography Literature dealing with the statistical and mathematical analysis of the size, composition, and distribution of human populations, and of the causes and consequences of changes in mortality, marriage, and migration. (Excludes fertility which is covered in a separate category) Environmental Health Public health issues involving efforts to prevent and control disease by controlling the environment. Gender and Health Inequalities that arise from the different roles of women and men and the consequences of that inequality on their lives, their health and well being. Health Communication Organized campaigns designed to instruct, disseminate information, or influence knowledge, attitudes, and practices of a population with regard to reproductive health issues. HIV/AIDS and Sexually Transmitted Diseases/Infections HIV infections, AIDS, diseases or infections which are transmitted primarily or exclusively through intimate sexual contact. Maternal and Child Health Programs to promote safe motherhood, breast-feeding, oral rehydration therapy, immunization, nutrition, growth monitoring, and other practices designed to ensure child survival for children under five-years old. Population and Environment Effects of overpopulation on ecology, natural resources, and environmental health. Related Reproductive Health Programs Organization, administration, delivery, and evaluation of related reproductive health services. Women in Development Effects of development on and programs especially for women and girls. |
#60
|
||||
|
||||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Òîëüêî ïîìíèòå: ôîðóì - íå çàìåíà î÷íîìó âðà÷ó, à ëå÷åíèå ïî èíòåðíåòó - ÷ðåâàòî ñìåðòüþ îò îïå÷àòêè. Ñ óâàæåíèåì, Ñåðãåé Àëåêñàíäðîâè÷. |